ReviewCureus2023

Safety and Efficacy of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors vs. Erythropoietin-Stimulating Agents in Treating Anemia in Renal Patients (With or Without Dialysis): A Meta-Analysis and Systematic Review.

Nanush Damarlapally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.